Literature DB >> 3235344

Rationale for elective modified neck dissection.

R M Byers1, P F Wolf, A J Ballantyne.   

Abstract

A retrospective study was conducted to give surgeons direction in deciding which type of modified neck dissection is proper elective treatment for the patient with a clinically negative neck. The medical records of 428 previously untreated patients (seen between January 1, 1970, and December 31, 1979) whose necks (i.e., NO) were electively dissected and who had had a primary squamous carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx were included. The three major types of modified neck dissections studied were the supraomohyoid, the anterior, and the functional. Sixteen percent (70 of 428) of the patients had multiple positive nodes and 6% (28 of 428) had evidence of extracapsular invasion. A unilateral supraomohyoid dissection was most often used for primaries of the oral cavity. Bilateral anterior dissection was common for cancers of the larynx and hypopharynx, and functional neck dissection was equally distributed among the primary sites. None of the patients with primaries of the larynx or hypopharynx had pathologically positive nodes in the submental or submaxillary triangles. Advanced T-stage was generally associated with a greater incidence of subclinically positive nodes. Thirty percent of the patients received postoperative radiotherapy. The total number of nodes removed, the number of positive nodes with or without extracapsular invasion, and the anatomic location of the positive nodes were correlated with the type of dissection, the stage and site of the primary cancer, the use of postoperative radiotherapy, the regional (neck) failure, and survival.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3235344     DOI: 10.1002/hed.2890100304

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  52 in total

Review 1.  Management of the clinically negative (N0) neck.

Authors:  Karen T Pitman; Robert Dean
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

2.  A rule-based model for local and regional tumor spread.

Authors:  Ira J Kalet; Mark Whipple; Silvia Pessah; Jerry Barker; Marry M Austin-Seymour; Linda G Shapiro
Journal:  Proc AMIA Symp       Date:  2002

Review 3.  Management of cervical metastasis.

Authors:  Eric J Lentsch
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

4.  Value of the supraomohyoid neck dissection with frozen section analysis as a staging procedure in the clinically negative neck in squamous cell carcinoma of the oral cavity.

Authors:  F J van den Hoogen; J J Manni
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

5.  Predictors of extracapsular spread in lymph node metastasis.

Authors:  Kadir Imre; Ercan Pinar; Semih Oncel; Caglar Calli; Bekir Tatar
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-09-27       Impact factor: 2.503

6.  Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.

Authors:  Sandra Schmitz; Jean-Pascal Machiels; Birgit Weynand; Vincent Gregoire; Marc Hamoir
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-22       Impact factor: 2.503

7.  Update on the classification and nomenclature system for neck dissection: revisions proposed by the Japan Neck Dissection Study Group.

Authors:  Yasuhisa Hasegawa; Masahisa Saikawa
Journal:  Int J Clin Oncol       Date:  2010-01-27       Impact factor: 3.402

Review 8.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

9.  Neurovascular Invasion and Histological Grade Serve as the Risk Factors of Cervical Lymph Node Metastases in Early Tongue Squamous Cell Carcinoma.

Authors:  Kailiu Wu; Xi Yang; Liwen Li; Min Ruan; Wei Liu; Wei Lu; Chenping Zhang; Siyi Li
Journal:  Mol Neurobiol       Date:  2015-04-25       Impact factor: 5.590

Review 10.  The diagnosis and treatment of oral cavity cancer.

Authors:  Klaus-Dietrich Wolff; Markus Follmann; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.